Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

Woori IO plans to accelerate its noninvasive CGM launch after FDA announced relaxed wearable device regulations.

At MD&M West, he will present “ The Needle Boom: Scaling Overmolded Needle Manufacturing for the At Home Care Revolution ,” ...

The mixed earnings report comes on the heels of the Abbott Park, IL-based company announcing it would acquire Exact Sciences for $21 billion.

This week's Medtech in a Minute features news about Boston Scientific and a potentially dangerous chemical used in IV bags ...

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

Industry consultant Michael Drues will discuss how medical device companies can better prepare for FDA inspections.

North Carolina becomes the second state to ban DEHP in medical devices, requiring IV bag manufacturers to phase out usage by 2030.

Torrington, CT-based Dymax will exhibit at MD&M West 2026, taking place February 3-5, at the Anaheim Convention Center in ...

Hellman & Friedman is reportedly looking to sell the drug-eluting stent pioneer for about $9 billion, according to a report ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.